DOCSLIB.ORG

Architecture of the Human XPC DNA Repair and Stem Cell Coactivator Complex

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Architecture of the Human XPC DNA Repair and Stem Cell Coactivator Complex Architecture of the human XPC DNA repair and stem cell coactivator complex Elisa T. Zhanga,b,c, Yuan Hed,1, Patricia Groba,b, Yick W. Fonga,b,2, Eva Nogalesa,b,d, and Robert Tjiana,b,c,e,3 aDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720; bHoward Hughes Medical Institute, Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720; cLi Ka Shing Center for Biomedical and Health Sciences, CIRM Center of Excellence, University of California Berkeley, CA 94720; dLife Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94710; and eHoward Hughes Medical Institute, Chevy Chase, MD 20815-6789 Contributed by Robert Tjian, October 16, 2015 (sent for review August 20, 2015; reviewed by Montserrat Samso and Ning Zheng) The Xeroderma pigmentosum complementation group C (XPC) involved in base excision repair (BER). BER is responsible for complex is a versatile factor involved in both nucleotide excision removing primarily non-helix-distorting lesions from the ge- repair and transcriptional coactivation as a critical component of nome (2). In BER, the XPC complex helps repair oxidative the NANOG, OCT4, and SOX2 pluripotency gene regulatory net- damage by stimulating the activities of DNA glycosylases such work. Here we present the structure of the human holo-XPC com- as OGG1 and TDG (3) to target lesions including 8-oxoguanine, plex determined by single-particle electron microscopy to reveal a independently of other downstream GG-NER factors (17). flexible, ear-shaped structure that undergoes localized loss of order More recently, the XPC complex has also been found to upon DNA binding. We also determined the structure of the complete perform crucial duties in the regulation of gene transcription, the yeast homolog Rad4 holo-complex to find a similar overall architec- second primary function of the genome. In embryonic stem cells ture to the human complex, consistent with their shared DNA repair (ESCs), the XPC complex acts as a coactivator to enhance the functions. Localized differences between these structures reflect an expression of OCT4- and SOX2-driven pluripotency genes, most intriguing phylogenetic divergence in transcriptional capabilities that notably NANOG (4), buttressing the gene regulatory network we present here. Having positioned the constituent subunits by tag- that establishes and maintains the unique self-renewal and plu- ging and deletion, we propose a model of key interaction interfaces ripotency properties of ESCs. The XPC complex performs its that reveals the structural basis for this difference in functional con- BIOCHEMISTRY servation. Together, our findings establish a framework for under- coactivator functions independently of DNA binding (4, 18), standing the structure-function relationships of the XPC complex in presumably by bridging interactions between the sequence-spe- the interplay between transcription and DNA repair. cific transcription factors OCT4 (octamer-binding transcrip- tion factor 4; also known as POU5F1) and SOX2 [SRY (sex- transcription | stem cells | DNA repair | structure | biochemistry determining region Y)-box 2] and the general transcriptional machinery, such as TFIID and RNA pol II, thus following a enomes of living organisms serve two primary functions: as mechanism reminiscent of that of other coactivator complexes Gvehicles for hereditary information and as the template for gene products involved in an organism’s development and re- Significance sponses to environmental stimuli. Vital to maintaining the health of genomes in the face of intrinsic and extrinsic sources of DNA Embryonic or pluripotent stem cells are unique in their ability to damage are a suite of DNA repair pathways, each dedicated to self-renew in culture and to generate all lineages of an adult or- handling specific lesions. Similarly, proper use and expression of ganism, making them valuable tools for modeling early de- this essential genomic information is regulated by a host of tran- velopmental processes and for developing regenerative medicine scription factors, chromatin remodelers, and epigenetic modifiers technologies. An important factor in controlling the expression of and readers (1). The Xeroderma pigmentosum complementation pluripotency genes is the Xeroderma pigmentosum complemen- group C (XPC) protein complex performs crucial roles in both tation group C (XPC) DNA repair complex. This study presents, to of these capacities by participating in nucleotide excision repair our knowledge, the first complete structures of different XPC complexes by electron microscopy to establish an important (NER) (2) and base excision repair (BER) (3), as well as transcrip- ’ tional regulation (4) and other processes (5). framework for a molecular understanding of XPC stwoprimary The XPC complex is one of seven XP complementation groups functions. In conjunction with our biochemical findings, we syn- thesize a model of how XPC performs both its evolutionarily A–G and is composed of the 125-kDa XPC, the 58-kDa RAD23B conserved DNA repair function and its evolutionarily noncon- (Rad23 homolog B; also known as HHR23B), and the 18-kDa served transcription function. CETN2 (Centrin2) subunits (2). RAD23B and CETN2 associate – tightly with XPC and stabilize both its DNA repair (6 10) and Author contributions: E.T.Z., E.N., and R.T. designed research; E.T.Z., Y.H., and Y.W.F. stem cell coactivator functions (4). The XPC complex is the ini- performed research; E.T.Z. and Y.W.F. contributed new reagents/analytic tools; E.T.Z., tiator and main DNA damage sensor in global genome nucleotide Y.H., P.G., and Y.W.F. analyzed data; and E.T.Z., E.N., and R.T. wrote the paper. excision repair (GG-NER), one of two branches of the nucleotide Reviewers: M.S., Virginia Commonwealth University; and N.Z., University of Washington. excision repair pathway that repairs a wide array of bulky, helix- The authors declare no conflict of interest. distorting lesions (2, 11); the second form of NER or transcrip- Data deposition: Atomic coordinates and structure factors have been deposited in the tion-coupled repair (TC-NER) targets lesions blocking tran- Electron Microscopy Data Bank (EMDB), https://www.ebi.ac.uk/pdbe/emdb/ (accession scription to reactivate proper gene expression (2, 12). Defects nos. EMD-6495–EMD-6498). 1 in GG-NER lead to photosensitivity and a predisposition to cer- Present address: Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208. tain cancers in animal models and in human patients with Xero- 2Present address: Brigham Regenerative Medicine Center, Cardiovascular Division, De- derma pigmentosum (13). In conjunction with the UV-damage partment of Medicine Brigham and Women’s Hospital, Harvard Medical School, Cam- DNA-binding protein (UV-DDB) (2, 12), the XPC complex bridge, MA 02139. recruits >30 downstream factors, such as XPA (14), TFIIH (15, 3To whom correspondence should be addressed. Email: [email protected]. 16), and the endonucleases XPF and XPG to remove these ad- This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. ducts (2, 11). In addition to its role in GG-NER, XPC is also 1073/pnas.1520104112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1520104112 PNAS | December 1, 2015 | vol. 112 | no. 48 | 14817–14822 Downloaded by guest on October 3, 2021 such as Mediator and p300/CBP (19). In a separate study, XPC TFIIH-BD1 DNA-BD A 124 144 607 742 was found to localize to active but not to inactive RNA pol II- XPA- & OGG1-BD OCT4-BD SOX2-BD 1 154 331 511 808 940 dependent gene promoters in the absence of exogenous geno- XPC TGD TGD BH1 BH2 BH3 204 223 496 734 814 toxic stress (11, 20). RAD23B-BD2 TFIIH-BD2 RAD23B-BD1 847 863 Although both the DNA repair and transcriptional functions 1 276 334 419 CETN2-BD RAD23B UbL of mammalian XPC complexes have been characterized bio- UBA1 XPC-BD UBA2 chemically and genetically, 3D structural information of the 1 172 CETN2 EF EF holo-complex has been unavailable. The partial crystal structure 105 166 XPC-BD of Rad4, the yeast homolog of the human XPC subunit, in B D R C complex with the Rad4-interaction domain of yeast Rad23, has XPC provided information helpful toward an understanding of Rad4/ XPC’s biochemical behavior and of certain phenotypic outcomes 180° 180° ’ (18, 21). However, given XPC s low sequence homology with the 170 Å yeast homolog Rad4 (21, 22), the absence of key domains in the available crystal structure, and the divergence of requirements for transcriptional vs. repair activities (4, 15, 18, 23), structural in- 100 Å formation of the complete, three-subunit, native human XPC R MBP C C E complex is much needed for an understanding of the functional XPC versatility of the XPC complex. At present, no information has 180° been reported on the overall architecture of the XPC holo- 180° complex, the possible large-scale conformational rearrangements UbL in XPC upon DNA-binding, or the extent of structural conser- UBA1 vation of the human XPC complex with homolog complexes. UBA2 Here we address the lack of structural data on human XPC using 3D single-particle reconstruction by electron microscopy Fig. 1. 3D reconstruction of the human XPC complex and localization of (EM) to characterize the overall architecture of XPC, as well as subunits. (A) Schematic representation of the subunits and domains of the genetic tagging and computational docking to locate the relative human XPC complex. Transglutaminase homology domain (TGD), β-hairpin positions of its constituent subunits. We also assess the confor- domains 1–3 (BH), ubiquitin-like domain (UbL), ubiquitin-associated domains 1 mational changes to the complex upon binding to DNA. Given and 2 (UBA), EF-hand domains (EF), and protein- and DNA-binding domains the evolutionary conservation of GG-NER (24), we queried the (BD) are indicated accordingly. (B) Front and back views of the XPC complex extent of structural and functional conservation over evolution- reconstructed in EMAN2 (49).
Load more

Recommended publications
  • DNA Repair with Its Consequences (E.G
    Cell Science at a Glance 515 DNA repair with its consequences (e.g. tolerance and pathways each require a number of apoptosis) as well as direct correction of proteins. By contrast, O-alkylated bases, Oliver Fleck* and Olaf Nielsen* the damage by DNA repair mechanisms, such as O6-methylguanine can be Department of Genetics, Institute of Molecular which may require activation of repaired by the action of a single protein, Biology, University of Copenhagen, Øster checkpoint pathways. There are various O6-methylguanine-DNA Farimagsgade 2A, DK-1353 Copenhagen K, Denmark forms of DNA damage, such as base methyltransferase (MGMT). MGMT *Authors for correspondence (e-mail: modifications, strand breaks, crosslinks removes the alkyl group in a suicide fl[email protected]; [email protected]) and mismatches. There are also reaction by transfer to one of its cysteine numerous DNA repair pathways. Each residues. Photolyases are able to split Journal of Cell Science 117, 515-517 repair pathway is directed to specific Published by The Company of Biologists 2004 covalent bonds of pyrimidine dimers doi:10.1242/jcs.00952 types of damage, and a given type of produced by UV radiation. They bind to damage can be targeted by several a UV lesion in a light-independent Organisms are permanently exposed to pathways. Major DNA repair pathways process, but require light (350-450 nm) endogenous and exogenous agents that are mismatch repair (MMR), nucleotide as an energy source for repair. Another damage DNA. If not repaired, such excision repair (NER), base excision NER-independent pathway that can damage can result in mutations, diseases repair (BER), homologous recombi- remove UV-induced damage, UVER, is and cell death.
    [Show full text]
  • DNA Proofreading and Repair
    DNA proofreading and repair Mechanisms to correct errors during DNA replication and to repair DNA damage over the cell's lifetime. Key points: Cells have a variety of mechanisms to prevent mutations, or permanent changes in DNA sequence. During DNA synthesis, most DNA polymerases "check their work," fixing the majority of mispaired bases in a process called proofreading. Immediately after DNA synthesis, any remaining mispaired bases can be detected and replaced in a process called mismatch repair. If DNA gets damaged, it can be repaired by various mechanisms, including chemical reversal, excision repair, and double-stranded break repair. Introduction What does DNA have to do with cancer? Cancer occurs when cells divide in an uncontrolled way, ignoring normal "stop" signals and producing a tumor. This bad behavior is caused by accumulated mutations, or permanent sequence changes in the cells' DNA. Replication errors and DNA damage are actually happening in the cells of our bodies all the time. In most cases, however, they don’t cause cancer, or even mutations. That’s because they are usually detected and fixed by DNA proofreading and repair mechanisms. Or, if the damage cannot be fixed, the cell will undergo programmed cell death (apoptosis) to avoid passing on the faulty DNA. Mutations happen, and get passed on to daughter cells, only when these mechanisms fail. Cancer, in turn, develops only when multiple mutations in division-related genes accumulate in the same cell. In this article, we’ll take a closer look at the mechanisms used by cells to correct replication errors and fix DNA damage, including: Proofreading, which corrects errors during DNA replication Mismatch repair, which fixes mispaired bases right after DNA replication DNA damage repair pathways, which detect and correct damage throughout the cell cycle Proofreading DNA polymerases are the enzymes that build DNA in cells.
    [Show full text]
  • The Consequences of Rad51 Overexpression for Normal and Tumor Cells
    dna repair 7 (2008) 686–693 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/dnarepair Mini review The consequences of Rad51 overexpression for normal and tumor cells Hannah L. Klein ∗ Department of Biochemistry, New York University School of Medicine, NYU Medical Center, 550 First Avenue, New York, NY 10016, United States article info abstract Article history: The Rad51 recombinase is an essential factor for homologous recombination and the Received 11 December 2007 repair of DNA double strand breaks, binding transiently to both single stranded and double Accepted 12 December 2007 stranded DNA during the recombination reaction. The use of a homologous recombination Published on line 1 February 2008 mechanism to repair DNA damage is controlled at several levels, including the binding of Rad51 to single stranded DNA to form the Rad51 nucleofilament, which is controlled through Keywords: the action of DNA helicases that can counteract nucleofilament formation. Overexpression Rad51 protein of Rad51 in different organisms and cell types has a wide assortment of consequences, rang- Overexpression of Rad51 ing from increased homologous recombination and increased resistance to DNA damaging Genomic instability agents to disruption of the cell cycle and apoptotic cell death. Rad51 expression is increased Tumor cell drug resistance in p53-negative cells, and since p53 is often mutated in tumor cells, there is a tendency for Homologous recombination Rad51 to be overexpressed in tumor cells, leading to increased resistance to DNA damage Gene targeting and drugs used in chemotherapies. As cells with increased Rad51 levels are more resis- tant to DNA damage, there is a selection for tumor cells to have higher Rad51 levels.
    [Show full text]
  • Defective DNA Repair and Chromatin Organization in Patients with Quiescent Systemic Lupus Erythematosus Vassilis L
    Souliotis et al. Arthritis Research & Therapy (2016) 18:182 DOI 10.1186/s13075-016-1081-3 RESEARCH ARTICLE Open Access Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus Vassilis L. Souliotis1,2*, Konstantinos Vougas3, Vassilis G. Gorgoulis3,4 and Petros P. Sfikakis2 Abstract Background: Excessive autoantibody production characterizing systemic lupus erythematosus (SLE) occurs irrespective of the disease’s clinical status and is linked to increased lymphocyte apoptosis. Herein, we tested the hypothesis that defective DNA damage repair contributes to increased apoptosis in SLE. Methods: We evaluated nucleotide excision repair at the N-ras locus, DNA double-strand breaks repair and apoptosis rates in peripheral blood mononuclear cells from anti-dsDNA autoantibody-positive patients (six with quiescent disease and six with proliferative nephritis) and matched healthy controls following ex vivo treatment with melphalan. Chromatin organization and expression levels of DNA repair- and apoptosis-associated genes were also studied in quiescent SLE. Results: Defective nucleotide excision repair and DNA double-strand breaks repair were found in SLE, with lupus nephritis patients showing higher DNA damage levels than those with quiescent disease. Melphalan-induced apoptosis rates were higher in SLE than control cells and correlated inversely with DNA repair efficiency. Chromatin at the N-ras locus was more condensed in SLE than controls, while treatment with the histone deacetylase inhibitor vorinostat resulted in hyperacetylation of histone H4, chromatin decondensation, amelioration of DNA repair efficiency and decreased apoptosis. Accordingly, genes involved in DNA damage repair and signaling pathways, such as DDB1, ERCC2, XPA, XPC, MRE11A, RAD50, PARP1, MLH1, MLH3, and ATM were significantly underexpressed in SLE versus controls, whereas PPP1R15A, BARD1 and BBC3 genes implicated in apoptosis were significantly overexpressed.
    [Show full text]
  • Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck
    1633 Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck Jiaze An,1 Zhensheng Liu,1 Zhibin Hu,1 Guojun Li,1 Li-E Wang,1 Erich M. Sturgis,1,2 AdelK. El-Naggar, 2,3 Margaret R. Spitz,1 and Qingyi Wei1 Departments of 1Epidemiology, 2Head and Neck Surgery, and 3Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas Abstract Susceptibility to cancer has been associated with DNA SCCHN risk (adjusted odds ratio, 1.65; 95% confidence repair capacity, a global reflection of all functional variants, interval, 1.16-2.36). In analysis of the joint effects, the most of which are relatively rare. Among the 1,098 single number of observed risk genotypes was associated with nucleotide polymorphisms (SNP) identified in the eight SCCHN risk in a dose-response manner (P for trend = 0.017) core nucleotide excision repair genes, only a few are and those who carried four or more risk genotypes exhibited common nonsynonymous or regulatory SNPs that are a borderline significant 1.23-fold increased SCCHN risk potentially functional. We tested the hypothesis that seven (adjusted odds ratio, 1.23; 95% confidence interval, 0.99-1.53). selected common nonsynonymous and regulatory variants In the stratified analysis, the dichotomized combined effect in the nucleotide excision repair core genes are associated of the seven SNPs was slightly more evident among older with risk of squamous cell carcinoma of the head and neck subjects, women, and laryngeal cancer. These findings (SCCHN) in a hospital-based, case-control study of 829 suggest that these potentially functional SNPs may collec- SCCHN cases and 854 cancer-free controls.
    [Show full text]
  • DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer Jinshengyu,1, 6 Mary A
    Human Cancer Biology DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer JinshengYu,1, 6 Mary A. Mallon,2 Wanghai Zhang,1, 6 Robert R. Freimuth,1,4 Sharon Marsh,1, 6 Mark A.Watson,4,6 PaulJ. Goodfellow,2,3,6 andHowardL.McLeod1,3,5,6 Abstract Background: The ability to maintain DNA integrity is a critical cellular function. DNA repair is conducted by distinct pathways of genes, many of which are thought to be altered in colorectal cancer. However, there has been little characterization of these pathways in colorectal cancer. Method: By using the TaqMan real-time quantitative PCR, RNA expression profiling of 20 DNA repair pathway genes was done in matched tumor and normal tissues from 52 patients with Dukes’C colorectal cancer. Results: The relative mRNA expression level across the 20 DNA repair pathway genes varied considerably, and the individual variability was also quite large, with an 85.4 median fold change in the tumor tissue genes and a 127.2 median fold change in the normal tissue genes. Tumor- normal differential expression was found in 13 of 20 DNA repair pathway genes (only XPA had a lower RNA level in the tumor samples; the other 12 genes had significantly higher tumor levels, all P < 0.01). Coordinated expression of ERCC6, HMG1, MSH2,andPOLB (RS z 0.60) was observed in the tumor tissues (all P < 0.001). Apoptosis index was not correlated with expression of the 20 DNA repair pathway genes. MLH1 and XRCC1 RNA expression was correlated with microsatellite instability status (P = 0.045 and 0.020, respectively).
    [Show full text]
  • Crystal Structure of the Werner's Syndrome Helicase
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.04.075176; this version posted May 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Crystal Structure of the Werner’s Syndrome Helicase Joseph A. Newman1, Angeline E. Gavard1, Simone Lieb2, Madhwesh C. Ravichandran2, Katja Hauer2, Patrick Werni2, Leonhard Geist2, Jark Böttcher2, John. R. Engen3, Klaus Rumpel2, Matthias Samwer2, Mark Petronczki2 and Opher Gileadi1,* 1- Structural Genomics Consortium, University of Oxford, ORCRB, Roosevelt Drive, Oxford, United Kingdom. 2- Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria. 3- Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA. Abstract Werner syndrome helicase (WRN) plays important roles in DNA repair and the maintenance of genome integrity. Germline mutations in WRN give rise to Werner syndrome, a rare autosomal recessive progeroid syndrome that also features cancer predisposition. Interest in WRN as a therapeutic target has increased massively following the identification of WRN as the top synthetic lethal target for microsatellite instable (MSI) cancers. High throughput screens have identified candidate WRN helicase inhibitors, but the development of potent, selective inhibitors would be significantly enhanced by high-resolution structural information.. In this study we have further characterized the functions of WRN that are required for survival of MSI cancer cells, showing that ATP binding and hydrolysis are required for complementation of siRNA-mediated WRN silencing. A crystal structure of the WRN helicase core at 2.2 Å resolutionfeatures an atypical mode of nucleotide binding with extensive contacts formed by motif VI, which in turn defines the relative positioning of the two RecA like domains.
    [Show full text]
  • A Novel Regulation Mechanism of DNA Repair by Damage-Induced and RAD23-Dependent Stabilization of Xeroderma Pigmentosum Group C Protein
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein Jessica M.Y. Ng,1 Wim Vermeulen,1 Gijsbertus T.J. van der Horst,1 Steven Bergink,1 Kaoru Sugasawa,3,4 Harry Vrieling,2 and Jan H.J. Hoeijmakers1,5 1MGC-Department of Cell Biology & Genetics, Centre for Biomedical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands; 2MGC-Department of Radiation Genetics and Chemical Mutagenesis, Leiden University Medical Center, 2333 AL Leiden, The Netherlands; 3Cellular Physiology Laboratory, RIKEN (The Institute of Physical and Chemical Research), and 4Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Wako, Saitama 351-0198, Japan Primary DNA damage sensing in mammalian global genome nucleotide excision repair (GG-NER) is performed by the xeroderma pigmentosum group C (XPC)/HR23B protein complex. HR23B and HR23A are human homologs of the yeast ubiquitin-domain repair factor RAD23, the function of which is unknown. Knockout mice revealed that mHR23A and mHR23B have a fully redundant role in NER, and a partially redundant function in embryonic development. Inactivation of both genes causes embryonic lethality, but appeared still compatible with cellular viability. Analysis of mHR23A/B double-mutant cells showed that HR23 proteins function in NER by governing XPC stability via partial protection against proteasomal degradation. Interestingly, NER-type DNA damage further stabilizes XPC and thereby enhances repair. These findings resolve the primary function of RAD23 in repair and reveal a novel DNA-damage-dependent regulation mechanism of DNA repair in eukaryotes, which may be part of a more global damage-response circuitry.
    [Show full text]
  • Roles of the Werner Syndrome Recq Helicase in DNA Replication
    dna repair 7 (2008) 1776–1786 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/dnarepair Mini-review Roles of the Werner syndrome RecQ helicase in DNA replication Julia M. Sidorova ∗ Department of Pathology, University of Washington, Seattle, WA 98195-7705, USA article info abstract Article history: Congenital deficiency in the WRN protein, a member of the human RecQ helicase family, Received 22 July 2008 gives rise to Werner syndrome, a genetic instability and cancer predisposition disorder with Accepted 23 July 2008 features of premature aging. Cellular roles of WRN are not fully elucidated. WRN has been Published on line 6 September 2008 implicated in telomere maintenance, homologous recombination, DNA repair, and other processes. Here I review the available data that directly address the role of WRN in preserv- Keywords: ing DNA integrity during replication and propose that WRN can function in coordinating Werner syndrome replication fork progression with replication stress-induced fork remodeling. I further dis- RecQ helicase cuss this role of WRN within the contexts of damage tolerance group of regulatory pathways, Human cell culture and redundancy and cooperation with other RecQ helicases. Replication stress Published by Elsevier B.V. Damage tolerance Contents 1. Introduction ................................................................................................................. 1777 1.1. Is S phase prolonged in WRN-deficient cells? ...................................................................... 1777 1.2. What is the mechanism of the S phase extension in the absence of WRN? ...................................... 1778 1.3. Are all forks equal when it comes to WRN? ........................................................................ 1779 1.4. A mechanistic model for WRN role in replication elongation ..................................................... 1779 1.5. WRN and damage tolerance pathways ............................................................................. 1781 1.6.
    [Show full text]
  • Nucleotide Excision Repair Gene Polymorphisms and Recurrence After Treatment for Superficial Bladder Cancer
    1408 Vol. 11, 1408–1415, February 15, 2005 Clinical Cancer Research Nucleotide Excision Repair Gene Polymorphisms and Recurrence after Treatment for Superficial Bladder Cancer Jian Gu,1 Hua Zhao,1 Colin P. Dinney,2 Yong Zhu,3 fewer putative high-risk alleles as the reference group, Dan Leibovici,2 Carlos E. Bermejo,2 individuals with six to seven risk alleles and individuals with eight or more risk alleles had higher recurrence risks, with H. Barton Grossman,2 and Xifeng Wu1 hazard ratios of 0.92 (0.54-1.57) and 2.53 (1.48-4.30), 1 2 Departments of Epidemiology and Urology, The University of Texas respectively (P for trend < 0.001). There was also a M.D. Anderson Cancer Center, Houston, Texas, and 3Department of Epidemiology and Public Health, Yale University, New Haven, significant trend for shorter recurrence-free survival time Connecticut with increasing number of variant alleles (log rank test, P = 0.0007). When we stratified the patients according to intravesical Bacillus Calmette-Guerin treatment, we found a ABSTRACT significant trend for shorter recurrence-free survival time in Purpose: Interindividual differences in DNA repair patients with variant alleles of XPA or ERCC6 polymor- capacity not only modify individual susceptibility to carci- phisms who received Bacillus Calmette-Guerin treatment nogenesis, but also affect individual response to cancer (log rank test, P = 0.078 and 0.022, respectively). There were treatment. Nucleotide excision repair (NER) is one of the no significant individual or joint associations between these major DNA repair pathways in mammalian cells involved in polymorphisms and progression.
    [Show full text]
  • Manuscript Details
    Manuscript Details Manuscript number CROH_2016_43 Title Biological and predictive role of ERCC1 polymorphisms in cancer Article type Review Article Abstract Excision repair cross-complementation group 1 (ERCC1) is a key component in DNA repair mechanisms and may influence the tumor DNA-targeting effect of the chemotherapeutic agent oxaliplatin. Germline ERCC1 polymorphisms may alter the protein expression and published data on their predictive and prognostic value have so far been contradictory. In the present article we review available evidence on the clinical role and utility of ERCC1 polymorphisms. No consistent associations with efficacy outcomes were found, while an increased oxaliplatin-related toxicity in patients carrying minor ERCC1 variants has been repeatedly documented Keywords ERCC1; oxaliplatin; single nucleotide polymorphisms; colorectal cancer Manuscript category Oncology Corresponding Author VINCENZO FORMICA Corresponding Author's Medical Oncology Unit, Tor Vergata University Hospital Institution Order of Authors VINCENZO FORMICA, Elena Doldo, Francesca Romana Antonetti, Antonella Nardecchia, Patrizia Ferroni, Silvia Riondino, Cristina Morelli, Hendrik-Tobias Arkenau, Fiorella Guadagni, Augusto Orlandi, Mario Roselli Suggested reviewers David Cunningham, Jeffrey Schlom, Michele Moschetta, Caroline Jochems Submission Files Included in this PDF File Name [File Type] cover.doc [Cover Letter] coi.doc [Conflict of Interest] CROH comments author.doc [Response to Reviewers] CROH comments.doc [Response to Reviewers (without Author Details)] paper 170113 REV.doc [Revised Manuscript with Changes Marked] paper 161025.doc [Manuscript (without Author Details)] Highlights.doc [Highlights] title.doc [Title Page (with Author Details)] To view all the submission files, including those not included in the PDF, click on the manuscript title on your EVISE Homepage, then click 'Download zip file'.
    [Show full text]
  • DNA Mismatch Repair and Oxidative DNA Damage: Implications for Cancer Biology and Treatment
    Cancers 2014, 6, 1597-1614; doi:10.3390/cancers6031597 OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Review DNA Mismatch Repair and Oxidative DNA Damage: Implications for Cancer Biology and Treatment Gemma Bridge †, Sukaina Rashid † and Sarah A. Martin * Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK; E-Mails: [email protected] (G.B.); [email protected] (S.R.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-20-7882-3599; Fax: +44-20-7882-3884. Received: 14 May 2014; in revised form: 2 July 2014 / Accepted: 18 July 2014 / Published: 5 August 2014 Abstract: Many components of the cell, including lipids, proteins and both nuclear and mitochondrial DNA, are vulnerable to deleterious modifications caused by reactive oxygen species. If not repaired, oxidative DNA damage can lead to disease-causing mutations, such as in cancer. Base excision repair and nucleotide excision repair are the two DNA repair pathways believed to orchestrate the removal of oxidative lesions. However, recent findings suggest that the mismatch repair pathway may also be important for the response to oxidative DNA damage. This is particularly relevant in cancer where mismatch repair genes are frequently mutated or epigenetically silenced. In this review we explore how the regulation of oxidative DNA damage by mismatch repair proteins may impact on carcinogenesis. We discuss recent studies that identify potential new treatments for mismatch repair deficient tumours, which exploit this non-canonical role of mismatch repair using synthetic lethal targeting.
    [Show full text]